Skip to content
  • My Profile
  • Register
  • Log In
  • Watchlist
AlphaStreet

Market Intelligence Ecosystem

  • News
          • Technology
          • Consumer
          • Health Care
          • Industrials
          • Retail
          • Finance
          • Energy
          • IPO
          • Leisure & Entertainment
          • Research Summary
          • Other Industries
  • News
    • Consumer
    • Energy
    • Finance
    • Health Care
    • Industrials
    • IPO
    • Leisure & Entertainment
    • Other Industries
    • Research Summary
    • Retail
    • Technology
  • AlphaGraphs
  • AlphaStreet Intelligence
  • Log In
  • Register
  • My Profile
  • Watchlist

Categories

  • CEO Insights
  • Fund Manager Insights
  • Concall Highlights
  • Analysis
  • Concall Transcripts
  • AlphaGraphs

API

Laurus Labs Q3FY23 net profit rises by 32 percent

March 1, 2023March 1, 2023
earnings preview

Pharmaceutical and biotechnology company Laurus Labs reported 32% year-on-year (YoY) rise in profit after tax to INR 203 crore for the quarter

Wockhardt posted a net loss of INR 102 Crores in Q3FY23

February 21, 2023February 21, 2023

Drugmaker Wockhardt posted a consolidated loss of ₹102 crore for the three months ended December 31, 2022. The company posted a profit

Lupin Q2FY23 results out: Net profit rises more than 100%

November 10, 2022November 10, 2022

Shares of Lupin gained as much as 8 percent in early trading on Thursday after the company returned to profitability during the

Divi’s Laboratories Ltd Q2 FY23 Earnings Conference Call Insights

November 8, 2022November 17, 2022

https://youtu.be/e1-tljnhSVM Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY23 Earnings Concall Management Update: [00:06:48] DIVISLAB stated that though global logistics scenario

Decoding India’s leading API development company – Dr Reddy’s Laboratories

October 20, 2022October 20, 2022

About Company:  Founded in 1984 and headquartered in Hyderabad, India, Dr Reddy’s Laboratories (DRL) is India’s second largest pharma company by global

Divi’s Laboratories Ltd Q1 FY23 Earnings Conference Call Insights

August 15, 2022October 6, 2022

https://youtu.be/EPaxfKgyoZQ Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Q&A Highlights: Tushar Manudhane from Motilal Oswal asked about the

Infographic: Divi’s Lab Q1 results out, Net profit rises 26%

August 12, 2022October 6, 2022

On Friday, Pharmaceuticals company Divis Laboratories reported a 26% rise in its consolidated net profit at ₹702 crore as compared to ₹557

Posts navigation

Newer posts

© 2020 AlphaStreet Inc. All Rights Reserved

Quick Links

  • AlphaGraphs
  • Earnings Transcripts
  • Earnings Calls
  • Contact
  • Company
  • The Team

Contact Info

info@alphastreet.com

44053 Fremont Blvd,
Fremont, CA 94538

Top